bluebird bio, Inc.
ANTI-BCMA CAR T CELL COMPOSITIONS
Last updated:
Abstract:
The invention provides improved anti-BCMA CAR T cell compositions for adoptive T cell therapy for relapsed/refractory multiple myeloma.
Status:
Application
Type:
Utility
Filling date:
3 Nov 2017
Issue date:
20 Aug 2020